Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Late-Onset Cytopenias and Therapy Related Myeloid Malignancies in a Cohort of Patients with Lymphoproliferative Disorders at Instituto Nacional De Cancerologia- Mexico

Adriana Palacios Campos, MD, Judith Monserrat Corona Herrera, MD, Eunice Fabián Morales, PhD, Myrna Candelaria, MDPharmD

Blood (2018) 132 (Supplement 1): 5514.

https://doi.org/10.1182/blood-2018-99-110458

Published: 2018

Journal Articles

Nanoparticle Design For Bone-Specific Chemotherapy and Microenvironmental Targeting In Multiple Myeloma

Michaela R Reagan, PhD, Archana Swami, PhD, Pamela A Basto, Yuji Mishima, PhD, Jinhe Liu, Siobhan Glavey, MD, Grace B O'Callaghan, PhD, Michele Moschetta, MD, Kenichi Nagano, DDS, Ph.D, Roland Baron, DDS, PhD, Aldo M Roccaro, MD, PhD, Omid Farokhzad, MD, Irene M. Ghobrial, MD

Blood (2013) 122 (21): 881.

https://doi.org/10.1182/blood.V122.21.881.881

Published: 2013

Journal Articles

Platelet activation and inhibition in polycythemia vera and essential thrombocythemia

Carlo Patrono, Bianca Rocca, Valerio De Stefano

Blood (2013) 121 (10): 1701–1711.

https://doi.org/10.1182/blood-2012-10-429134

Published: 2013

Journal Articles

Nrf2 Deficiency Leads to Reduced Hematopoietic Stem Cell Self-Renewal and Increased Sensitivity to Genotoxic Stressors Through Impaired P53 Function

Liang Li, PhD, Yin Wei Ho, Ling Li, PhD, Qin Huang, MD, PhD, Min Li, PhD, Stephen J. Forman, MD, Smita Bhatia, MD, MPH, Ravi Bhatia, MD

Blood (2012) 120 (21): 397.

https://doi.org/10.1182/blood.V120.21.397.397

Published: 2012

Journal Articles

Mangiferin Reduced Etoposide-Induced DNA Damage in Mononuclear Human Umbilical Cord Blood Cells Via Activating Nrf2-Mediated Signaling

Shanshan Li, Benping Zhang, Linglan Zeng, Yan Chen, Jun Fang

Blood (2011) 118 (21): 4626.

https://doi.org/10.1182/blood.V118.21.4626.4626

Published: 2011

Journal Articles

Targeting AKT Signaling in Pediatric Acute Lymphoblastic Leukemia with Sulforaphane

Koramit Suppipat, MD, Evelyn Zhu, Daniel Lacorazza, PhD

Blood (2011) 118 (21): 1521.

https://doi.org/10.1182/blood.V118.21.1521.1521

Published: 2011

Journal Articles

Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator

Yan Jiao, John Wilkinson, IV, Xiumin Di, Wei Wang, Heather Hatcher, Nancy D. Kock, Ralph D'Agostino, Jr, Mary Ann Knovich, Frank M. Torti, Suzy V. Torti

Blood (2009) 113 (2): 462–469.

https://doi.org/10.1182/blood-2008-05-155952

Published: 2009

Includes: Supplemental data

Journal Articles

Sulforaphane and PEITC Augment Activity of Conventional and Novel Anti-Myeloma Drugs

Jana Jakubikova, Jan Sedlak, Steffen Klippel, Merav Leiba, Yu-Tzu Tai, Teru Hideshima, Klaus Podar, Dharminder Chauhan, Noopur Raje, Paul G. Richardson, Kenneth C. Anderson, Constantine S. Mitsiades

Blood (2008) 112 (11): 2648.

https://doi.org/10.1182/blood.V112.11.2648.2648

Published: 2008

Journal Articles

Green Tea Catechin Epigallocatechin-3-Gallate (EGCG) Induces Cell Death in Acute Myeloid Leukemic Cells Via DAPK2 and Potentiates ATRA-Induced Neutrophil Differentiation

Adrian Britschgi, MSc, Hans-Uwe Simon, MD, PhD, Andreas Tobler, MD, Martin F. Fey, MD, Mario P. Tschan, PhD

Blood (2008) 112 (11): 2628.

https://doi.org/10.1182/blood.V112.11.2628.2628

Published: 2008

Journal Articles

Intermediate Dose Intravenous Methotrexate (MTX) Dramatically Reduces the Risk of Secondary Central Nervous System (CNS) Lymphoma.

Ephraim P. Hochberg, MD, Peter Hammerman, MD, Tak Takvorian, MD, Christiana Toomey, James Michaelson, PhD, Aliyah Rahemtullah, MD, Jeremy S. Abramson, MD

Blood (2007) 110 (11): 3442.

https://doi.org/10.1182/blood.V110.11.3442.3442

Published: 2007

Journal Articles

Fenretinide (4HPR) Inhibits Growth of Myeloma Cells in Their Microenvironment and Is a Potent Inhibitor of Angiogenesis and Osteoclastogenesis.

Xin Li, PhD, Wen Ling, Rinku Saha, Paul Perkins, Angela Pennisi, Shmuel Yaccoby, Ph.D.

Blood (2006) 108 (11): 3480.

https://doi.org/10.1182/blood.V108.11.3480.3480

Published: 2006

Journal Articles

Synergistic Anticancer Effects between Curcumin and Doxorubicin in Drug Sensitive and Resistant Human Pediatric Leukemic Cell Lines.

Cheppail Ramachandran, PhD, P.K. Raveendran Nair, Ph.D., Enrique Escalon, MD, Steven J. Melnick, Ph.D, MD, Ziad Khatib, MD

Blood (2006) 108 (11): 4361.

https://doi.org/10.1182/blood.V108.11.4361.4361

Published: 2006

Journal Articles

New Pinostilbene Analogues Overcome Anthracycline Resistance in Acute Lymphoplastic Leukemia Ex Vivo .

Banu Katik, Anja Selig, Janna Velder, PhD, Elvira E. Shults, PhD, Thomas Wieder, PhD, Guenter Henze, MD, Hans-Guenther Schmalz, PhD, Aram Prokop, MD, PhD

Blood (2006) 108 (11): 4403.

https://doi.org/10.1182/blood.V108.11.4403.4403

Published: 2006

Journal Articles

Xanthohumol Induces Apoptosis in B-CLL In Vitro by Sustained Endoplasmic Reticulum Stress and Inhibition of NFκ-B.

Sofie Lust, Barbara Vanhoecke, PhD, Mireille Van Gele, Mary Kaileh, Jerina Boelens, MD, Martine Poelman, MD, Wim VandenBerghe, PhD, Jan Philippé, MD PhD, Fritz Offner, MD PhD

Blood (2006) 108 (11): 4979.

https://doi.org/10.1182/blood.V108.11.4979.4979

Published: 2006

Journal Articles

Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications

Masood A. Shammas, Paola Neri, Hemanta Koley, Ramesh B. Batchu, Robert C. Bertheau, Vidit Munshi, Rao Prabhala, Mariateresa Fulciniti, Yu tzu Tai, Steven P. Treon, Raj K. Goyal, Kenneth C. Anderson, Nikhil C. Munshi

Blood (2006) 108 (8): 2804–2810.

https://doi.org/10.1182/blood-2006-05-022814

Published: 2006

Journal Articles

Novel Stilbene-Based Antileukemic Agents Active in P-Glycoprotein Expressing and Apoptosis-Resistant Acute Leukaemia Cell Lines.

Stefania Grimaudo, Antonietta Di Cristina, Vincenzo Abbadessa, Simoni Daniele, Marinella Roberti, Manlio Tolomeo

Blood (2005) 106 (11): 4436.

https://doi.org/10.1182/blood.V106.11.4436.4436

Published: 2005

Journal Articles

Green Tea Component, Catechin, Induces Apoptosis of Myeloid Leukemic Cells Via Myeloperoxidase (MPO)-Dependent Highly Reactive Oxygen Species (ROS) Production.

Tomonori Nakazato, MD, Kenji Yamato, MD, Morihiko Sagawa, MD, Yuriko Nishiyama, MD, Yasuo Ikeda, MD, Masahiro Kizaki, MD

Blood (2005) 106 (11): 4429.

https://doi.org/10.1182/blood.V106.11.4429.4429

Published: 2005

Journal Articles

Apoptotic Cross-Talk between Organelles Induced by Fenretinide in Hematopoietic Malignancy.

Kankan Wang, MD, PhD, Dakai Xiao, Ph.D., Yanzhi Du, Ph.D, Huiyong Fan, B.Sci, Yulong Chen, B.Sci, Saijuan Chen, MD, Ph.D, Zhu Chen, MD, Ph.D, Ji Zhang, Ph. D.

Blood (2005) 106 (11): 4430.

https://doi.org/10.1182/blood.V106.11.4430.4430

Published: 2005

Journal Articles

Specific Killing of Multiple Myeloma Cancer Cells by Epigallocatechin-3-Gallate Extracted from Green Tea.

Masood A. Shammas, PhD, Hemanta Koley, PhD, Ramesh B. Batchu, PhD, Paola Neri, PhD, Pierfrancesco Tassone, PhD, Rao Prabhala, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2004) 104 (11): 2461.

https://doi.org/10.1182/blood.V104.11.2461.2461

Published: 2004

Journal Articles

A Green Tea Component, Catechin, Induces Apoptosis of Human Myeloma Cells and Markedly Enhances Arsenic Trioxide-Induced Cytotoxicity Via Production of Reactive Oxygen Species (ROS).

Tomonori Nakazato, MD, Keisuke Ito, MD, Yoshitaka Miyakawa, MD, Yasuo Ikeda, MD, Masahiro Kizaki, MD

Blood (2004) 104 (11): 2475.

https://doi.org/10.1182/blood.V104.11.2475.2475

Published: 2004

NARROW

Late-Onset Cytopenias and Therapy Related Myeloid Malignancies in a Cohort of Patients with Lymphoproliferative Disorders at Instituto Nacional De Cancerologia- Mexico

Nanoparticle Design For Bone-Specific Chemotherapy and Microenvironmental Targeting In Multiple Myeloma

Platelet activation and inhibition in polycythemia vera and essential thrombocythemia

Nrf2 Deficiency Leads to Reduced Hematopoietic Stem Cell Self-Renewal and Increased Sensitivity to Genotoxic Stressors Through Impaired P53 Function

Mangiferin Reduced Etoposide-Induced DNA Damage in Mononuclear Human Umbilical Cord Blood Cells Via Activating Nrf2-Mediated Signaling

Targeting AKT Signaling in Pediatric Acute Lymphoblastic Leukemia with Sulforaphane

Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator

Sulforaphane and PEITC Augment Activity of Conventional and Novel Anti-Myeloma Drugs

Green Tea Catechin Epigallocatechin-3-Gallate (EGCG) Induces Cell Death in Acute Myeloid Leukemic Cells Via DAPK2 and Potentiates ATRA-Induced Neutrophil Differentiation

Intermediate Dose Intravenous Methotrexate (MTX) Dramatically Reduces the Risk of Secondary Central Nervous System (CNS) Lymphoma.

Fenretinide (4HPR) Inhibits Growth of Myeloma Cells in Their Microenvironment and Is a Potent Inhibitor of Angiogenesis and Osteoclastogenesis.

Synergistic Anticancer Effects between Curcumin and Doxorubicin in Drug Sensitive and Resistant Human Pediatric Leukemic Cell Lines.

New Pinostilbene Analogues Overcome Anthracycline Resistance in Acute Lymphoplastic Leukemia Ex Vivo .

Xanthohumol Induces Apoptosis in B-CLL In Vitro by Sustained Endoplasmic Reticulum Stress and Inhibition of NFκ-B.

Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications

Novel Stilbene-Based Antileukemic Agents Active in P-Glycoprotein Expressing and Apoptosis-Resistant Acute Leukaemia Cell Lines.

Green Tea Component, Catechin, Induces Apoptosis of Myeloid Leukemic Cells Via Myeloperoxidase (MPO)-Dependent Highly Reactive Oxygen Species (ROS) Production.

Apoptotic Cross-Talk between Organelles Induced by Fenretinide in Hematopoietic Malignancy.

Specific Killing of Multiple Myeloma Cancer Cells by Epigallocatechin-3-Gallate Extracted from Green Tea.

A Green Tea Component, Catechin, Induces Apoptosis of Human Myeloma Cells and Markedly Enhances Arsenic Trioxide-Induced Cytotoxicity Via Production of Reactive Oxygen Species (ROS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only